Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

4.975 +0.275 (+5.85%)
Streaming Delayed Price Updated: 12:53 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
Via ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
Via ACCESSWIRE
What's Happening With Sonnet BioTherapeutics (SONN) Shares?
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 8.5% to $1.18 Thursday morning on downward momentum. 
Via Benzinga
Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% to 33,025.71 while the NASDAQ fell 2.45% to 12,817.76.... 
Via Benzinga
Topics Stocks
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Crude Oil Edges Higher; Thermo Fisher Scientific Cuts FY23 Forecast
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 150 points on Wednesday. The Dow traded up 0.20% to 33,206.51 while the NASDAQ fell 1.76% to... 
Via Benzinga
Topics Stocks
Why Sonnet BioTherapeutics (SONN) Stock Is Getting Hammered
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 27.6% to $1.31 Wednesday morning after the company announced the pricing of a public offering involving 2,843,750 shares... 
Via Benzinga
EVGO Stock Slips as TD Cowen Downgrades EVgo
EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut. 
Via InvestorPlace
Nasdaq Down 1.5%; Microsoft Posts Upbeat Results
U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded down 0.26% to 33,053.68 while the NASDAQ fell 1.50% to... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Is InMed Pharmaceuticals (INM) Stock Down 25% Today?
InMed Pharmaceuticals stock is falling on Wednesday after shares of INM underwent a massive rally on Tuesday alongside study results. 
Via InvestorPlace
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?
Sonnet BioTherapeutics stock is dropping on Wednesday after the company revealed the pricing of a public offering for SONN shares. 
Via InvestorPlace
Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million... 
Via Benzinga
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 369 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology
Via ACCESSWIRE
Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 175 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 57 companies reached new 52-week lows. 
Via Benzinga
Why Sonnet BioTherapeutics Stock (SONN) Is Getting Obliterated
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 24% to $0.21 Thursay afternoon after the company announced a 1-for-22 reverse stock split. 
Via Benzinga
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
Via ACCESSWIRE
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.